Pharma Whistle Blower Blog

Amerisource has agreed to pay $625 million to resolve fraud allegations raised by three whistleblower lawsuits. Omni Healthcare Inc., an oncology practice, and two pharmacy workers, Daniel Sypula and Kelly Hodge sued the pharmaceutical company alleging that they had contaminated and illegally...

Pharm D Solutions LLC is a newcomer to the pharmaceutical industry. FDA records suggest the company has been operating since 2014. The company’s website claims it opened its doors in 2015.
Pharm D Solutions operates as a national compounding pharmacy. According to its marketing...

“Real Breaking News!” India’s leading cGMP offender has now imported their deviant behaviors to its sterile products USA facility! Wochardt has been the subject of huge recalls and import bans by FDA over non-compliance of cGMPs, and now the FDA is apparently quite upset that...

“Driven to Suicide by Pressure to Sell Medicine.” That was a page one headline in the New York Times this week. Two Times journalists tell the tragic story of Ashish Awasthi, a 27-year-old sales rep for Abbott Laboratories, one America’s largest pharmaceutical companies. Awasthi...

On July 4, 2016, the New York Times reported that Teva Pharmaceuticals wants to join PhRMA, the Big Pharma traced group: Pharmaceutical Research and Manufacturers Association of America. There’s only one BIG issue: Teva the world’s largest generic pharmaceuticals manufacturer, with a...

On June 14th, The International Journal of Health Services reported that over the last 18 years, 17 different drugs were approved for patient use and later pulled because they were unsafe. That may not sound like much but those 17 prescription drugs were prescribed 112 million times. Nine of these...

The U.S. Food and Drug Administration issued an alert for counterfeit BiCNU, an FDA approved cancer drug. Also known as carmustine, BiCNU is an injectable medication used to treat brain cancer, multiple myeloma, and lymphoma (Hodgkin’s and non-Hodgkin’s). Although there is no known...

The US FDA has finally released the long-awaited 483 Warning Letter for the incredible cGMP violations found in a January-February 2015 inspection at Emcure’s Hinjawadi plant in Pune, Maharashtra India. The plant was quickly banned by FDA in March 2015 from importing any drugs into the USA....

Mistakes happen. We hear stories every week about prescription drugs that are sub-potent or superpotent. Very often the drugs in our medicine cabinets are subpotent meaning they have insufficient Active Pharmaceutical Ingredient (API). Frequently these poor quality drugs are manufactured in India...

Whistleblower remains anonymous for fear of retaliation, allegations are under internal investigation
According to a whistleblower who has chosen to remain anonymous, Swiss drugmaker Novartis bribed government officials in Turkey to obtain advantages that may have translated into $85 million...